EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Increasing bowel cancer screening using SMS in general practice: the SMARTscreen cluster randomised trial

Jennifer G McIntosh iD, Mark Jenkins iD, Anna Wood iD, Patty Chondros iD, Tina Campbell, Edweana Wenkart, Clare O'Reilly, Ian Dixon, Julie Toner, Javiera Martinez-Gutierrez, Linda Govan, Jon D Emery iD

British Journal of General Practice · 2024

DOI: 10.3399/bjgp.2023.0230 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of General Practice, 2024. Verfasst von Jennifer G McIntosh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne. Hauptthemen laut MEDLINE: Colorectal Neoplasms, General Practice. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Australia has one of the highest incidences of colorectal cancer (CRC) worldwide. The Australian National Bowel Cancer Screening Program (NBCSP) is a best-practice, organised screening programme, but uptake is low (40.9%) and increasing participation could reduce morbidity and mortality associated with CRC. Endorsement by GPs is strongly associated with increasing screening uptake.

Aim

This study (SMARTscreen) aimed to test whether a multi-intervention short message service (SMS) sent by general practices to 50–60-year-old patients who were due to receive the NBCSP kit would increase NBCSP uptake, by comparing it with usual care. Design and setting A stratified cluster randomised controlled trial was undertaken, involving 21 Australian general practices in Western Victoria, Australia.

Method

For intervention practices, people due to receive the NBCSP kit within a 6-month study period were sent an SMS just before receiving the kit. The SMS included a personalised message from the person’s general practice endorsing the kit, a motivational narrative video, an instructional video, and a link to more information. Control practices continued with usual care, comprising at-home testing with a faecal immunochemical test (FIT) through the NBCSP. The primary outcome was the between-arm percentage difference in uptake of FIT screening within 12 months from randomisation, which was estimated using generalised linear model regression.

Results

In total, 39.2% (1143/2914) of people in 11 intervention practices and 23.0% (583/2537) of people in 10 control practices had a FIT result in their electronic health records — a difference of 16.5% (95% confidence interval = 2.02 to 30.9).

Conclusion

The SMS intervention increased NBCSP kit return in 50–60-year-old patients in general practice. This finding informed a larger trial — SMARTERscreen — to test this intervention in a broader Australian population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsGeneral PracticeHumansMiddle AgedAustraliaEarly Detection of CancerFamily PracticeMass Screening

Stichwörter der Autor:innen

bowel cancer screeningcolorectal cancergeneral practiceprimary health care

Autor:innen und Institutionen

  • Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne.
  • Department of General Practice and Primary Care, University of Melbourne, Melbourne.
  • Healthily Pty Ltd, Melbourne.
  • Pen Computer Systems, Sydney.
  • Workforce Development, Screening Early Detection and Immunisation, Cancer Council Victoria, Melbourne, and executive manager, Chronic Health, Population Health Unit, VACCHO, Melbourne.
  • Melbourne.

ORCID-Profile: Jennifer G McIntosh, Mark Jenkins, Anna Wood, Patty Chondros, Jon D Emery

Zitieren

APA

McIntosh, J. G., Jenkins, M., Wood, A., Chondros, P., Campbell, T., Wenkart, E., O'Reilly, C., Dixon, I., Toner, J., Martinez-Gutierrez, J., Govan, L., & Emery, J. D. (2024). Increasing bowel cancer screening using SMS in general practice: the SMARTscreen cluster randomised trial. British Journal of General Practice. https://doi.org/10.3399/bjgp.2023.0230

Vancouver

McIntosh JG, Jenkins M, Wood A, Chondros P, Campbell T, Wenkart E, et al. Increasing bowel cancer screening using SMS in general practice: the SMARTscreen cluster randomised trial. British Journal of General Practice. 2024. doi:10.3399/bjgp.2023.0230

BibTeX
@article{McIntosh2024,
  author = {McIntosh, Jennifer G and Jenkins, Mark and Wood, Anna and Chondros, Patty and Campbell, Tina and Wenkart, Edweana and O'Reilly, Clare and Dixon, Ian and Toner, Julie and Martinez-Gutierrez, Javiera and Govan, Linda and Emery, Jon D},
  title = {Increasing bowel cancer screening using SMS in general practice: the SMARTscreen cluster randomised trial},
  journal = {British Journal of General Practice},
  year = {2024},
  doi = {10.3399/bjgp.2023.0230}
}
Kostenlos starten →